| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS42000526 | EBV | ENSG00000074410.14 | protein_coding | CA12 | No | No | 771 | B3KUB4 O43570 |
| TVIS10040395 | HBV | ENSG00000074410.14 | protein_coding | CA12 | No | No | 771 | B3KUB4 O43570 |
| TVIS10040396 | HBV | ENSG00000074410.14 | protein_coding | CA12 | No | No | 771 | B3KUB4 O43570 |
| TVIS44011028 | HTLV-1 | ENSG00000074410.14 | protein_coding | CA12 | No | No | 771 | B3KUB4 O43570 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | CA12 |
|---|---|
| DrugBank ID | DB00909 |
| Drug Name | Zonisamide |
| Target ID | BE0001653 |
| UniProt ID | O43570 |
| Regulation Type | inhibitor |
| PubMed IDs | 19703035; 18537527; 18782051; 17762320; 17582922 |
| Citations | De Simone G, Scozzafava A, Supuran CT: Which carbonic anhydrases are targeted by the antiepileptic sulfonamides and sulfamates? Chem Biol Drug Des. 2009 Sep;74(3):317-21. doi: 10.1111/j.1747-0285.2009.00857.x.@@Supuran CT, Di Fiore A, De Simone G: Carbonic anhydrase inhibitors as emerging drugs for the treatment of obesity. Expert Opin Emerg Drugs. 2008 Jun;13(2):383-92. doi: 10.1517/14728214.13.2.383 .@@Farooq MU, Moore PW, Bhatt A, Aburashed R, Kassab MY: Therapeutic role of zonisamide in neuropsychiatric disorders. Mini Rev Med Chem. 2008 Sep;8(10):968-75.@@Biton V: Clinical pharmacology and mechanism of action of zonisamide. Clin Neuropharmacol. 2007 Jul-Aug;30(4):230-40.@@Authors unspecified: Zonisamide: new drug. No advantage in refractory partial epilepsy. Prescrire Int. 2007 Jun;16(89):95-7. |
| Groups | Approved; Investigational |
| Direct Classification | Benzisoxazoles |
| SMILES | NS(=O)(=O)CC1=NOC2=CC=CC=C12 |
| Pathways | |
| PharmGKB | PA451978 |
| ChEMBL | CHEMBL750 |
